Pelabresib Plus Jakafi Maintains Efficacy in JAK-Naive Myelofibrosis
Adding pelabresib to a JAK inhibitor may improve multiple aspects of myelofibrosis, including spleen size, symptoms and bone marrow fibrosis.
Adding pelabresib to a JAK inhibitor may improve multiple aspects of myelofibrosis, including spleen size, symptoms and bone marrow fibrosis.
Nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) was approved by the FDA for subcutaneous injection across approved solid tumor indications for nivolumab (Opdivo).
CURE® provides a space that highlights the voices of patients with cancer, survivors, caregivers, and advocates. Read personal stories on CURE’s blog page.
Aim(s) To describe the characteristics and perceived effectiveness of clinical supervision mental health nurses are receiving and further explore any statistical correlations between the perceived…
A nursing associate has been raising the profile of their profession through a regular podcast which challenges the stigma around the role.
No significant survival benefits were found when comparing three CDK4/6 inhibitor combinations with initial treatment for HR-positive, HER2-negative metastatic breast cancer.
As a nurse practitioner (NP), you know first-hand about your patients’ needs and the challenges many people face when they encounter barriers to health care…
Often mistaken as a synonym for hospice care, palliative care can be critical for patients with cancer and serious illnesses.
Community nurses have been introduced to an ambulance control room to link-up services and improve response times this winter.
Extreme winter pressures and a flu ‘tidal wave’ have exposed the ‘cavernous gap’ between low numbers of nurses and rising demands
Lead nurse at West Leeds PCN Ruth Colbeck responds to an article about the roles of nurses and GPs in general practice